These features highlight the therapeutic potential of RXFP1 activation for the treatment of heart failure, pulmonary arterial hypertension, liver and kidney fibrosis, scleroderma, or idiopathic pulmonary fibrosis. This evidence concerns the gene RXFP1 and heart failure.